Registration

WINNING STRATEGIES WASHINGTON for KALEO

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical drug development

LobbyistCovered position, as disclosed
SCOTT MACKENZIE New —
MICHAEL A MEROLA New Deputy CoS, Sen. Torricelli
CHARLA PENN New LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
ROBERT ZUCKER New LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lauten

Pharmacy PHA

Pharmaceutical drug development

LobbyistCovered position, as disclosed
SCOTT MACKENZIE New —
MICHAEL A MEROLA New Deputy CoS, Sen. Torricelli
CHARLA PENN New LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
ROBERT ZUCKER New LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lauten

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.